These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. 4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine. Guinn BA; DeBenedette MA; Watts TH; Berinstein NL J Immunol; 1999 Apr; 162(8):5003-10. PubMed ID: 10202049 [TBL] [Abstract][Full Text] [Related]
6. CD8+ T cells induce complete regression of advanced ovarian cancers by an interleukin (IL)-2/IL-15 dependent mechanism. Yang T; Wall EM; Milne K; Theiss P; Watson P; Nelson BH Clin Cancer Res; 2007 Dec; 13(23):7172-80. PubMed ID: 18056198 [TBL] [Abstract][Full Text] [Related]
7. Arming tumor-reactive T cells with costimulator B7-1 enhances therapeutic efficacy of the T cells. Zheng G; Liu S; Wang P; Xu Y; Chen A Cancer Res; 2006 Jul; 66(13):6793-9. PubMed ID: 16818656 [TBL] [Abstract][Full Text] [Related]
8. Bryostatin 1/ionomycin (B/I) ex vivo stimulation preferentially activates L-selectinlow tumor-sensitized lymphocytes. Chin CS; Miller CH; Graham L; Parviz M; Zacur S; Patel B; Duong A; Bear HD Int Immunol; 2004 Sep; 16(9):1283-94. PubMed ID: 15262898 [TBL] [Abstract][Full Text] [Related]
9. B7-1 and 4-1BB ligand expression on a myeloma cell line makes it possible to expand autologous tumor-specific cytotoxic T cells in vitro. Lu ZY; Condomines M; Tarte K; Nadal L; Delteil MC; Rossi JF; Ferrand C; Klein B Exp Hematol; 2007 Mar; 35(3):443-53. PubMed ID: 17309825 [TBL] [Abstract][Full Text] [Related]
10. 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses. Tan JT; Whitmire JK; Ahmed R; Pearson TC; Larsen CP J Immunol; 1999 Nov; 163(9):4859-68. PubMed ID: 10528187 [TBL] [Abstract][Full Text] [Related]
11. 4-1BBL costimulation retrieves CD28 expression in activated T cells. Habib-Agahi M; Jaberipour M; Searle PF Cell Immunol; 2009; 256(1-2):39-46. PubMed ID: 19217084 [TBL] [Abstract][Full Text] [Related]
12. The systemic administration of Ig-4-1BB ligand in combination with IL-12 gene transfer eradicates hepatic colon carcinoma. Xu DP; Sauter BV; Huang TG; Meseck M; Woo SL; Chen SH Gene Ther; 2005 Oct; 12(20):1526-33. PubMed ID: 15973445 [TBL] [Abstract][Full Text] [Related]
13. Aspergillus fumigatus extract differentially regulates antigen-specific CD4+ and CD8+ T cell responses to promote host immunity. Tao J; Segal BH; Eppolito C; Li Q; Dennis CG; Youn R; Shrikant PA J Leukoc Biol; 2006 Sep; 80(3):529-37. PubMed ID: 16793916 [TBL] [Abstract][Full Text] [Related]
14. A novel antibody-4-1BBL fusion protein for targeted costimulation in cancer immunotherapy. Müller D; Frey K; Kontermann RE J Immunother; 2008 Oct; 31(8):714-22. PubMed ID: 18779748 [TBL] [Abstract][Full Text] [Related]
15. Accumulation in tumor tissue of adoptively transferred T cells: A comparison between intravenous and intraperitoneal injection. Petersen CC; Petersen MS; Agger R; Hokland ME J Immunother; 2006; 29(3):241-9. PubMed ID: 16699367 [TBL] [Abstract][Full Text] [Related]
17. Type 1 CD8+ T cells are superior to type 2 CD8+ T cells in tumor immunotherapy due to their efficient cytotoxicity, prolonged survival and type 1 immune modulation. Ye Z; Tang C; Xu S; Zhang B; Zhang X; Moyana T; Yang J; Xiang J Cell Mol Immunol; 2007 Aug; 4(4):277-85. PubMed ID: 17764618 [TBL] [Abstract][Full Text] [Related]
18. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells. Habib-Agahi M; Phan TT; Searle PF Int Immunol; 2007 Dec; 19(12):1383-94. PubMed ID: 17977894 [TBL] [Abstract][Full Text] [Related]
19. The CD8 T cell response to vaccinia virus exhibits site-dependent heterogeneity of functional responses. Xiao Z; Curtsinger JM; Prlic M; Jameson SC; Mescher MF Int Immunol; 2007 Jun; 19(6):733-43. PubMed ID: 17545279 [TBL] [Abstract][Full Text] [Related]
20. Delivery of CCL21 to metastatic disease improves the efficacy of adoptive T-cell therapy. Thanarajasingam U; Sanz L; Diaz R; Qiao J; Sanchez-Perez L; Kottke T; Thompson J; Chester J; Vile RG Cancer Res; 2007 Jan; 67(1):300-8. PubMed ID: 17210711 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]